(Photo by Eric Miguel on Shutterstock)
In A Nutshell
- Researchers found that brewed coffee and many of its chemical compounds bind directly to NR4A1, a protein that helps the body manage stress, inflammation, and aging-related damage.
- Decaffeinated coffee produced the same NR4A1-related effects as regular coffee, suggesting caffeine is not the key driver of coffee’s health benefits.
- All experiments were conducted in lab cell lines, not in humans, and the concentrations needed to produce effects exceed typical levels found in human blood after drinking coffee.
A cup of coffee does more than deliver a caffeine jolt. Research from Texas A&M University suggests that brewed coffee and many of its chemical ingredients latch onto a specific protein in the body, one tied to stress defense, inflammation control, and even lifespan. Scientists have long observed that coffee drinkers tend to live longer and develop fewer age-related diseases, but a clear biological explanation has remained elusive. This new work may point toward one.
At the center of the Nutrients paper is a protein called NR4A1, a nuclear receptor that influences how the body handles stress, inflammation, and metabolism. It switches on when the body faces threats, helping protect organs and tissues from damage. Researchers found that brewed coffee and several of its individual compounds bind directly to this protein, activating NR4A1-related responses in lab experiments.
For a beverage that represents only a small fraction of anyone’s diet, having a shared biological target for so many of its ingredients could help explain why coffee punches far above its weight when it comes to health.
Why Coffee’s Health Benefits Have Been Hard to Explain
Many population studies have linked coffee drinking with lower mortality and lower risk of several age-related diseases, including heart disease, certain cancers, Parkinson’s disease, dementia, and metabolic disorders. Coffee has even been connected to better survival after breast and colon cancer diagnoses and fewer complications following certain surgeries. Scientists have struggled to explain why a single beverage could have such wide-ranging associations. This new research points to NR4A1 as a missing piece of that puzzle.
Led by Stephen Safe at Texas A&M’s College of Veterinary Medicine, the research team started by brewing coffee the way most people do at home. Ground or espresso coffee was added to boiling water, stirred for eight to ten minutes, then filtered. Beans came from Honduras, Mexico, Guatemala, El Salvador, and Colombia, including both regular and decaffeinated varieties.
Researchers then tested these coffee extracts, along with individual chemical compounds found in brewed coffee, in a series of lab experiments. They used a type of cancer cell called Rh30, drawn from a rare muscle cancer. These cells were chosen not because the study is about cancer treatment, but because they respond strongly to NR4A1 activity, making them a useful testing ground for whether a substance interacts with this protein.
To determine whether coffee compounds physically attach to NR4A1, the researchers used two methods. One measured changes in light emitted by the protein when compounds were added, a technique that reveals binding. Another detected when molecules stick to a surface coated with the protein. Both approaches confirmed that coffee extracts and several individual coffee compounds bind directly to NR4A1.
Coffee Compounds That Activate NR4A1
Brewed coffee extracts from every origin tested bound to NR4A1 and slowed the growth of Rh30 cancer cells. When researchers used a genetic technique to remove the NR4A1 protein from those same cells, the growth-slowing effects of the coffee extracts weakened considerably. This strongly suggests that coffee’s ability to affect these cells depends, at least in part, on its interaction with NR4A1.
Individual compounds told a similar story. Caffeic acid, ferulic acid, chlorogenic acid, and p-coumaric acid, all plant-based chemicals found in brewed coffee, bound tightly to the protein. Among these, caffeic acid gripped NR4A1 most firmly.
Two other coffee compounds, kahweol and cafestol, waxy substances unique to coffee, also bound NR4A1 and slowed cancer cell growth in a way that depended on the protein. Computer modeling showed these compounds attach to a different spot on the protein than the plant-based acids do, raising the possibility that multiple coffee ingredients could work on the same protein simultaneously through different entry points.
Caffeine told a more complicated story. It did bind to NR4A1, but its effects on NR4A1-related activity were weak and inconsistent across different tests. Quinic acid, another major coffee component, behaved similarly. Researchers described both as “selective and relatively weak functional NR4A1 ligands,” meaning they attach to the protein but don’t reliably trigger the same responses as the plant-based acids and waxy compounds.
That finding matters because caffeine may be coffee’s most famous ingredient, but when it comes to activating this particular protein, it appears far less potent than several of coffee’s lesser-known compounds. Colombian decaffeinated coffee extracts also slowed cancer cell growth through NR4A1, further undermining the idea that caffeine is the “active ingredient” behind coffee’s health benefits.
What NR4A1 Does and Why It Matters for Aging
Researchers also tested coffee compounds in immune cells called macrophages, the body’s front-line defenders against infection and inflammation. When these cells were exposed to a bacterial toxin that triggers inflammation, treatment with ferulic acid, chlorogenic acid, and caffeic acid reduced a marker of that inflammatory response. This mirrors what happens when known NR4A1-activating drugs are used, providing additional evidence that these coffee compounds can engage this protein beyond the cancer cells used in earlier experiments.
NR4A1 gets switched on rapidly when the body faces stress or inflammation. In prior mouse research cited by the authors, functional NR4A1 was associated with a longer lifespan than loss of NR4A1, with one study finding NR4A1-expressing mice lived approximately four months longer than those without the receptor. In humans, NR4A1 levels appear to decline with age, potentially leaving older adults more vulnerable to the very diseases that coffee consumption seems to protect against.
Researchers propose that NR4A1 functions as a kind of nutritional sensor, a protein that detects health-protective chemicals in food and activates the body’s defenses accordingly. Previous work had already shown that resveratrol, found in red grapes, and certain plant compounds in vegetables bind NR4A1. Adding coffee’s compounds to that list widens the range of dietary chemicals that may work through this single protein.
There are important caveats. This study was conducted entirely in lab cell lines, not in human subjects or animal models. Individual coffee compounds needed concentrations well above what is typically found in human blood after drinking coffee to show effects on cancer cells. Researchers acknowledge that brewed coffee’s real-world benefits likely come from the combined action of its more than 1,000 individual chemical components working together, with NR4A1 activation being just one contributing factor among many.
Still, identifying a shared target for so many different coffee ingredients is a concrete step forward. Rather than each compound acting through its own unrelated mechanism, this research points to a single protein that many of coffee’s healthiest ingredients appear to activate. And because this same protein responds to protective chemicals in grapes and vegetables too, it may eventually help explain why plant-rich diets broadly are linked to longer, healthier lives. Confirming whether these interactions play out meaningfully inside the human body will require further research, but for now, the morning cup is looking considerably more interesting at the molecular level.
Disclaimer: This research does not establish that coffee prevents, treats, or reverses any disease or condition. Readers should not modify their diet or health practices based on this study alone. Consult a qualified healthcare provider with any questions about diet and health.
Paper Notes
Limitations
This study was conducted entirely in laboratory cell lines, primarily Rh30 cancer cells and RAW264.7 immune cells, and did not involve human subjects or animal models. Researchers acknowledge that results need to be confirmed in non-cancerous tissues and organs. Concentrations of individual compounds required to produce effects in cancer cells (above 100 micromolar) exceed what is typically found in human blood after drinking coffee. Caffeine blood levels in humans are in the low micromolar range, while concentrations of plant-based compounds are likely much lower and have not been well defined. Coffee extraction was designed to mimic home brewing, and other preparation methods would likely produce extracts with different activity. Functional effects of caffeine and quinic acid as NR4A1 ligands were inconsistent and variable, requiring further investigation. All experiments were conducted as biological triplicates.
Funding and Disclosures
Research was supported by Texas A&M AgriLife and the Institute of Advancing Health Through Agriculture (IHA), with additional support from CPRIT (RP230204). Authors declared no conflicts of interest. Coffee samples were provided by Roger Norton from the Texas A&M Center for Coffee Research and Education; additional ground and espresso coffee was purchased from Polite Coffee Roasters in Bryan, Texas.
Publication Details
The paper, “Brewed Coffee and Its Components Act Through Orphan Nuclear Receptor 4A1 (NR4A1),” was published in Nutrients (2026, Volume 18, Issue 6, Article 877). Corresponding author: Stephen Safe, Department of Veterinary Physiology and Pharmacology, College of Veterinary Medicine, Texas A&M University. Additional authors: Amanuel Hailemariam, Srijana Upadhyay, Arafat Rahman Oany, Wai Ning Tiffany Tsui, Vinod Srivastava, Gargi Sivaram, Kelly Churion, Robert S. Chapkin, Laurie A. Davidson, Shoshana Eitan, James J. Cai, and Roger Norton, affiliated with multiple departments across Texas A&M University. DOI: 10.3390/nu18060877. Published open access under Creative Commons Attribution license.







